ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
121.721,43
-0,51%
S&P 500
5.996,66
1,00%
US Dollar vs BRL
6,0762
-0,07%
Bitcoin
107.601,78
4,35%
Brent Oil
79,765
-0,56%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Marinus Pharmaceuticals Inc (MRNS)

  7. Marinus Pharmaceuticals Inc (MRNS) Notícias

MRNS

Marinus Pharmaceuticals (MRNS)

Marinus Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:MRNS
DataHoraFonteTítuloCódigoCompanhia
08/01/202518:41Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:MRNSMarinus Pharmaceuticals Inc
07/01/202521:15Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
02/01/202517:25Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:MRNSMarinus Pharmaceuticals Inc
30/12/202409:11Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:MRNSMarinus Pharmaceuticals Inc
30/12/202409:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
30/12/202409:00Business WireImmedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.NASDAQ:MRNSMarinus Pharmaceuticals Inc
10/12/202417:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
14/11/202420:39Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
14/11/202417:04Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
12/11/202418:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRNSMarinus Pharmaceuticals Inc
12/11/202418:00Business WireMarinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:MRNSMarinus Pharmaceuticals Inc
24/10/202409:00Business WireMarinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic AlternativesNASDAQ:MRNSMarinus Pharmaceuticals Inc
17/10/202408:00Business WireMarinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual MeetingNASDAQ:MRNSMarinus Pharmaceuticals Inc
15/10/202417:00Business WireMarinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY® Titration RegimensNASDAQ:MRNSMarinus Pharmaceuticals Inc
09/10/202408:00Business WireMarinus Pharmaceuticals Announces Podium and Poster Presentations at the Neurocritical Care Society 2024 Annual MeetingNASDAQ:MRNSMarinus Pharmaceuticals Inc
08/10/202417:04Business WireMarinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:MRNSMarinus Pharmaceuticals Inc
20/09/202409:00Business WireMarinus Pharmaceuticals to Highlight Clinical Progress and Commercial Launch Preparedness for ZTALMY® in TSC at Investor and Analyst DayNASDAQ:MRNSMarinus Pharmaceuticals Inc
12/09/202409:00Business WireMarinus Pharmaceuticals Announces Agenda and Speakers for Investor & Analyst Day on September 20, 2024NASDAQ:MRNSMarinus Pharmaceuticals Inc
10/09/202409:00Business WireMarinus Pharmaceuticals to Present at the 2024 Cantor Global Healthcare ConferenceNASDAQ:MRNSMarinus Pharmaceuticals Inc
19/08/202409:00Business WireMarinus Pharmaceuticals to Host Investor and Analyst Day on Friday, September 20, 2024NASDAQ:MRNSMarinus Pharmaceuticals Inc
13/08/202408:00Business WireMarinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial ResultsNASDAQ:MRNSMarinus Pharmaceuticals Inc
07/08/202417:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
05/08/202406:45PR Newswire (US)Marinus Pharmaceuticals, Inc. Class Action: The Gross Law Firm Reminds Marinus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2024 - MRNSNASDAQ:MRNSMarinus Pharmaceuticals Inc
30/07/202409:00Business WireMarinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2024 Financial Results on August 13, 2024NASDAQ:MRNSMarinus Pharmaceuticals Inc
25/07/202406:45PR Newswire (US)The Gross Law Firm Notifies Marinus Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRNSNASDAQ:MRNSMarinus Pharmaceuticals Inc
18/07/202408:00Business WireMarinus Pharmaceuticals Announces Ganaxolone Approved in China as First Treatment for Seizures Associated with CDKL5 Deficiency DisorderNASDAQ:MRNSMarinus Pharmaceuticals Inc
17/07/202406:45PR Newswire (US)Marinus Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before August 5, 2024 to Discuss Your Rights - MRNSNASDAQ:MRNSMarinus Pharmaceuticals Inc
12/07/202406:45PR Newswire (US)Shareholders that lost money on Marinus Pharmaceuticals, Inc.(MRNS) should contact The Gross Law Firm about pending Class Action - MRNSNASDAQ:MRNSMarinus Pharmaceuticals Inc
03/07/202406:45PR Newswire (US)The Gross Law Firm Reminds Marinus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2024 - MRNSNASDAQ:MRNSMarinus Pharmaceuticals Inc
28/06/202406:45PR Newswire (US)Marinus Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before August 5, 2024 to Discuss Your Rights - MRNSNASDAQ:MRNSMarinus Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:MRNS

Seu Histórico Recente

USOTC
AMKYF
ABC Mart (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados